Acinetobacter ursingii: Difference between revisions
From IDWiki
Acinetobacter ursingii
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
*Rare cause of disease in humans |
*Rare cause of disease in humans |
||
*Mostly affects immunocompromised patients or critically ill patients |
*Mostly affects immunocompromised patients or critically ill patients |
||
*Possible association with malignancy |
|||
==Clinical Manifestations== |
==Clinical Manifestations== |
||
| Line 18: | Line 19: | ||
*[[Urinary tract infection]] |
*[[Urinary tract infection]] |
||
*Hospital-associated pneumonia |
*Hospital-associated pneumonia |
||
== Management == |
|||
* Often susceptible, but should still treat broadly (e.g. [[meropenem]]) and narrow based on susceptibilities |
|||
==Further Reading== |
==Further Reading== |
||
Latest revision as of 14:44, 7 February 2021
Background
Microbiology
- Non-motile, aerobic, oxidase negative, non-fermentative, Gram-negative coccobacillus
- Member of the genus Acinetobacter with low pathogenicity
Epidemiology
- Rare cause of disease in humans
- Mostly affects immunocompromised patients or critically ill patients
- Possible association with malignancy
Clinical Manifestations
- Primary bacteremia
- Urinary tract infection
- Hospital-associated pneumonia
Management
- Often susceptible, but should still treat broadly (e.g. meropenem) and narrow based on susceptibilities
Further Reading
- A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. BMC Infect Dis. 2015;15(400). doi: 10.1186/s12879-015-1145-z
- Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. J Clin Microbiol. 2006;44(12):4471-4478. doi: 10.1128/JCM.01535-06
